DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous STADA expands branded product strategy 16.09.2014 / 09:00 --------------------------------------------------------------------- Bad Vilbel/Huddersfield, September 16, 2014 - On the occasion of today's Capital Markets Day, which takes place at STADA's newest subsidiary, Thornton & Ross, Chief Financial Officer of STADA Helmut Kraft affirms the Group's focus on the strengthened expansion of the Branded Products segment. With additional acquisitions, progressing internationalization and centralized portfolio management, STADA intends to exceed the one billion euro mark in sales for branded products in the medium term. "In the future, we will increasingly leverage synergies for the international positioning of our branded products. With the introduction of a centralized portfolio management structure and the advantages of decentralized marketing, we take account of the growing importance of this segment within the Group. We consistently follow our strategy of launching existing branded products in new markets and further expanding the portfolio at the same time", says Helmut Kraft in his presentation. In line with the topic of focus, STADA's Executive Board invited analysts to this year's Capital Markets Day held in Huddersfield, the headquarters of OTC supplier Thornton & Ross. The number 4 in the British OTC market has been part of the STADA Group since last autumn. Thornton & Ross acts as a "Center of OTC Excellence" where new branded products are worked on for Group companies worldwide. "For STADA, Thornton & Ross is not just an ideal addition in the British market, the company makes a large overall contribution to the expansion of STADA's branded products strategy with its long-standing experience and high level of expertise in the area of branded products", explains Luc Slegers, Senior Vice President Europe at STADA. In light of current events, Dmitry Efimov, CEO STADA CIS, has informed the participants of market developments and trends in Russia and has highlighted the expectations of STADA's Executive Board regarding an upswing in the local business in the fourth quarter of the current financial year. Overall, the Executive Board of STADA affirms its outlook for financial year 2014 with slight growth in Group sales, adjusted EBITDA and adjusted net income. All of the presentations shown at the Capital Markets Day are available on STADA's website under Investor Relations at: www.stada.com/cmd2014. Additional information for journalists: STADA Arzneimittel AG / Media Relations / StadastraÃe 2-18 / 61118 Bad Vilbel - Germany / Phone: +49 (0) 6101 603-165 / Fax: +49 (0) 6101 603-506 / e-mail: press@stada.de Additional information for analysts: STADA Arzneimittel AG / Investor Relations / StadastraÃe 2-18 / 61118 Bad Vilbel - Germany / Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-506 / e-mail: communications@stada.de Or visit us in the Internet at www.stada.com. --------------------------------------------------------------------- 16.09.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG StadastraÃe 2-18 61118 Bad Vilbel Germany Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de Internet: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 287159 16.09.2014
DGAP-News: STADA expands branded product strategy
Top 10 Most Recent News Articles
Xerox Faces Probes After $130M Profit Forecast Slash
When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...
Continue Reading
ATTACK SHARK's X60: A New Era in Gaming Audio
Gaming Audio Gets a Power Boost with X60 We're diving headfirst into an era where gaming headsets promise more bells and whistles than ever before. This isn't just some random gadget plopped on the market. ATTACK SHARK's X60 Gaming Headset is strutting in, guns blazing, ready to take on the heavyweights in the competitive gaming world. It's not just about being another...
Continue Reading
DAR Logs Massive 587,000 Service Hours Nationwide
A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...
Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?
A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...
Continue Reading
CopperWood Senior Living Revives Historic Campus
A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...
Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market
Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...
Continue Reading
David Cornue Brings Story Insights to SXSW 2027
Crafting Stories with Precision: Cornue's Return In the world where Austin becomes a melting pot of ideas every spring, the return of David Cornue to SXSW casts a familiar, yet electrifying spark. This best-selling author and television whiz is slated to share his story magic at two workshops: one in the Lifestyle track and the other in the Film & TV track. Folks on-site...
Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos
Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...
Continue Reading
Ashling's New Feat: Microsoft Recognition in AI
Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...
Continue Reading
Maison Martell Bridging Artistry: Davido Meets Prince Gyasi
Maison Martell Dances to a New Beat The world's oldest cognac house, Maison Martell, is mixing things up in a way that’ll make your typical whiskey-on-the-rocks seem like child’s play. They've snagged Afrobeat heavyweight Davido and renowned visual poet Prince Gyasi to spin a fresh narrative, one where melody and imagery play in harmony. While this ain't your usual...
Continue ReadingTop 5 Most Recently Viewed Articles
RXO, Inc. Facilitates Resale of Common Stock by Stakeholders
RXO, Inc. Facilitates Resale of Common Stock RXO, Inc. (NYSE: RXO), a notable player in the transportation services sector, has taken an important step by filing a prospectus with the Securities and Exchange Commission (SEC). This prospectus outlines the plan for the resale of common stock by certain stockholders, allowing them access to the public market for their...
Continue Reading
Dendi Partners with Molecular Lab to Revolutionize Lab Solutions
Dendi and Molecular Lab Partners Forge Strategic Alliance Dendi, a prominent provider of cloud-native laboratory information systems, is joining forces with Molecular Lab Partners (MLP), a consultancy known for its high-complexity lab implementations. This strategic partnership aims to revolutionize the landscape of in-house clinical labs. By merging Dendi's innovative...
Continue Reading
Orla Mining's Earnings Predictions and Market Insights
Anticipated Earnings Release for Orla Mining Orla Mining (AMEX: ORLA) is set to unveil its quarterly earnings, and investors are keenly observing the upcoming report. Analysts are projecting the company will announce an earnings per share (EPS) of $0.20, which generates a mix of anticipation and excitement in the market. Insights Into Previous Earnings Performance In the...
Continue Reading
Understanding Intuitive Machines Stock Trends and Insights
What's Happening with Intuitive Machines Stock? Intuitive Machines, Inc. (NASDAQ: LUNR) has been experiencing a positive trading session recently. Analysts from Clear Street have maintained a favorable outlook, giving a Buy rating and increasing the target price from $17 to $25. Factors Behind the Positive Outlook Clear Street's outlook was influenced by Intuitive...
Continue Reading
AdvanSix Receives USDA Grant for Ammonium Sulfate Production
AdvanSix Receives $12 Million USDA Grant AdvanSix (NYSE: ASIX), a notable company in the diverse chemistry industry, has made an exciting announcement. The firm is set to receive a significant grant of $12 million from the U.S. Department of Agriculture (USDA) to enhance its production of granular ammonium sulfate. This financial support is part of the USDA's Fertilizer...
Continue Reading